Back to Trades
Total Value
$398.1K
Filing Date
Feb 17, 2026
1 transactions
Trade Summary
On Feb 12, 2026, Martens Rachel Yap, SVP, Partnerships & Corp Strat, reported $398.1K of LEXICON PHARMACEUTICALS, INC. (LXRX) across 1 transactions. The filing covers company securities and reflects balanced net activity of $0. Reported prices ranged from $1.37. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- LEXICON PHARMACEUTICALS, INC.
- Ticker Symbol
- LXRX
- CIK
- 0001062822
Insider Information
- Role
- SVP, Partnerships & Corp Strat
- Location
- THE WOODLANDS, TX
Filing Details
- Filing Date
- Feb 17, 2026
- Transaction Date
- Feb 12, 2026
- Accession Number
- 0001062822-26-000025
- Form Type
- 4
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Feb 12, 2026 | LXRX derivative | 193,740 | — | Grant/Award | — |
| Feb 12, 2026 | LXRX derivative | 290,620 | $1.37 | Grant/Award | $398.1K |
Want live alerts when Martens Rachel Yap trades again?
Download Insider Trades to track LXRX, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Each restricted stock unit represents a contingent right to receive one share of common stock.
- (F2)Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
- (F3)Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.